Related references
Note: Only part of the references are listed.Safety of influenza vaccines in pregnant women
Flor M. Munoz
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study
B. Rousseau et al.
ANNALS OF ONCOLOGY (2012)
Safety and Immunogenicity of 2009 Pandemic H1N1 Influenza Vaccination in Perinatally HIV-1-Infected Children, Adolescents, and Young Adults
Patricia M. Flynn et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Immunogenicity and Tolerability after Two Doses of Non-Adjuvanted, Whole-Virion Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Individuals
Heimo Lagler et al.
PLOS ONE (2012)
Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?
Eduardo F. Borba et al.
RHEUMATOLOGY (2012)
Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients
Yu-Tzu Chang et al.
VACCINE (2012)
Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situation
Heimo Lagler et al.
VACCINE (2012)
Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients
Paungpaga Lertdumrongluk et al.
VACCINE (2012)
Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients
Oriol Manuel et al.
CLINICAL INFECTIOUS DISEASES (2011)
Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine
William W. Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for Physicians
William H. Shrank et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2011)
Immunogenicity of an Inactivated Monovalent 2009 H1N1 Influenza Vaccine in Pregnant Women
Lisa A. Jackson et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial
Odile Launay et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Safety of Influenza A (H1N1) Vaccine in Postmarketing Surveillance in China.
Xiao-Feng Liang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Meta-Analysis of the Immunogenicity and Tolerability of Pandemic Influenza A 2009 (H1N1) Vaccines
Lamberto Manzoli et al.
PLOS ONE (2011)
Methods in vaccine effectiveness and safety studies: A critical need for vaccine confidence
Steven J. Jacobsen et al.
VACCINE (2011)
Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children
Wanatpreeya Phongsamart et al.
VACCINE (2011)
Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects
Naoki Yanagisawa et al.
VACCINE (2011)
Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: A prospective cohort study
Fernanda Tavares et al.
VACCINE (2011)
Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination
Elisabetta Parretta et al.
VACCINE (2011)
A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: Safety and immunity
Chun-Chi Lu et al.
VACCINE (2011)
Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010
Maja Folkenberg et al.
VACCINE (2011)
Informal Network of Communication Tools Played an Important Role in Sharing Safety Information on H1N1 Influenza Vaccine
Haruka Nakada et al.
CLINICAL INFECTIOUS DISEASES (2010)
Risk of Fatal Adverse Events after H1N1 Influenza Vaccine: Limitations of Passive Surveillance Data
Michael M. McNeil et al.
CLINICAL INFECTIOUS DISEASES (2010)
Risk of Fatal Adverse Events after H1N1 Influenza Vaccination
Haruka Nakada et al.
CLINICAL INFECTIOUS DISEASES (2010)
H1N1 vaccine safety monitoring: beyond background rates
Frank DeStefano et al.
LANCET (2010)
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials
Eric Plennevaux et al.
LANCET (2010)
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial
Xiao-Feng Liang et al.
LANCET (2010)
Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial
Zoltan Vajo et al.
LANCET (2010)
Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials
Raburn M. Mallory et al.
PLOS ONE (2010)
Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010
Claudia Vellozzi et al.
VACCINE (2010)
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
Ken M. Kunisaki et al.
LANCET INFECTIOUS DISEASES (2009)
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine.
Michael E. Greenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Adverse event detection in drug development: Recommendations and obligations beyond phase 3
Jesse A. Berlin et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2008)
Mortality reduction with influenza vaccine in patients with pneumonia outside Flu season - Pleiotropic benefits or residual confounding?
Dean T. Eurich et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy
Lone Simonsen et al.
LANCET INFECTIOUS DISEASES (2007)
Influenza vaccination and mortality:: prospective cohort study of the elderly in a large geographical area
A. Oertqvist et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease
Petar Mamula et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease
A Holvast et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis -: Safety and immunogenicity
F Del Porto et al.
VACCINE (2006)
Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients
A de Roux et al.
VACCINE (2006)
Immune response to influenza vaccination in children and adults with asthma: Effect of corticosteroid therapy
NA Hanania et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Influenza vaccination and Guillain Barre syndrome
MR Geier et al.
CLINICAL IMMUNOLOGY (2003)
Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users
A Amendola et al.
JOURNAL OF MEDICAL VIROLOGY (2001)
Share Paper
